Atlas Trials

Phase I Study of Continuous Administration of Salvianolic Acid A Tablet

Clinical trial NCT03908242 · UNKNOWN

Trial details

NCT number
NCT03908242
Sponsor
Peking University First Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes
Start date
2019-04-08
Primary completion
2019-04-30
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.